D168E (p.Asp168Glu) variant of LDLR (Low-density lipoprotein receptor)

D168E (p.Asp168Glu) in LDLR (Low-density lipoprotein receptor) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as conflicting interpretations in the context of Cardiovascular phenotype; Familial hypercholesterolemia; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.19 / 1. The record also includes population frequency data, published literature, and structural context.

D168E (p.Asp168Glu) variant details